Literature DB >> 25156420

TGFβ in T cell biology and tumor immunity: Angel or devil?

Eric Tu1, Pei Zhi Cheryl Chia1, Wanjun Chen2.   

Abstract

The evolutionally conserved transforming growth factor β (TGFβ) affects multiple cell types in the immune system by either stimulating or inhibiting their differentiation and function. Studies using transgenic mice with ablation of TGFβ or its receptor have revealed the biological significance of TGFβ signaling in the control of T cells. However, it is now clear that TGFβ is more than an immunosuppressive cytokine. Disruption of TGFβ signaling pathway also leads to impaired generation of certain T cell populations. Therefore, in the normal physiological state, TGFβ actively maintains T cell homeostasis and regulates T cell function. However, in the tumor microenvironment, TGFβ creates an immunosuppressive milieu that inhibits antitumor immunity. Here, we review recent advances in our understanding of the roles of TGFβ in the regulation of T cells and tumor immunity. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25156420      PMCID: PMC4182110          DOI: 10.1016/j.cytogfr.2014.07.014

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  215 in total

Review 1.  Tumor antigen-specific T helper cells in cancer immunity and immunotherapy.

Authors:  K L Knutson; M L Disis
Journal:  Cancer Immunol Immunother       Date:  2005-01-27       Impact factor: 6.968

2.  Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-beta 1.

Authors:  L D Johns; K C Flanders; G E Ranges; S Sriram
Journal:  J Immunol       Date:  1991-09-15       Impact factor: 5.422

3.  Characterizing the protective component of the alphabeta T cell response to transplantable squamous cell carcinoma.

Authors:  Michael Girardi; David Oppenheim; Earl J Glusac; Renata Filler; Allan Balmain; Robert E Tigelaar; Adrian C Hayday
Journal:  J Invest Dermatol       Date:  2004-03       Impact factor: 8.551

Review 4.  Adoptive immunotherapy of cancer using CD4(+) T cells.

Authors:  Pawel Muranski; Nicholas P Restifo
Journal:  Curr Opin Immunol       Date:  2009-03-13       Impact factor: 7.486

5.  Adaptive immunity maintains occult cancer in an equilibrium state.

Authors:  Catherine M Koebel; William Vermi; Jeremy B Swann; Nadeen Zerafa; Scott J Rodig; Lloyd J Old; Mark J Smyth; Robert D Schreiber
Journal:  Nature       Date:  2007-11-18       Impact factor: 49.962

6.  Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy.

Authors:  C Marcela Diaz-Montero; Mohamed Labib Salem; Michael I Nishimura; Elizabeth Garrett-Mayer; David J Cole; Alberto J Montero
Journal:  Cancer Immunol Immunother       Date:  2008-04-30       Impact factor: 6.968

7.  Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer.

Authors:  Lin Zhang; Jose R Conejo-Garcia; Dionyssios Katsaros; Phyllis A Gimotty; Marco Massobrio; Giorgia Regnani; Antonis Makrigiannakis; Heidi Gray; Katia Schlienger; Michael N Liebman; Stephen C Rubin; George Coukos
Journal:  N Engl J Med       Date:  2003-01-16       Impact factor: 91.245

8.  iNKT cell development is orchestrated by different branches of TGF-beta signaling.

Authors:  Jean-Marc Doisne; Laurent Bartholin; Kai-Ping Yan; Céline N Garcia; Nadia Duarte; Jean-Benoît Le Luduec; David Vincent; Farhan Cyprian; Branka Horvat; Sylvie Martel; Ruth Rimokh; Régine Losson; Kamel Benlagha; Julien C Marie
Journal:  J Exp Med       Date:  2009-05-18       Impact factor: 14.307

9.  TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function.

Authors:  Liang Zhou; Jared E Lopes; Mark M W Chong; Ivaylo I Ivanov; Roy Min; Gabriel D Victora; Yuelei Shen; Jianguang Du; Yuri P Rubtsov; Alexander Y Rudensky; Steven F Ziegler; Dan R Littman
Journal:  Nature       Date:  2008-03-26       Impact factor: 49.962

10.  Costimulatory molecules on immunogenic versus tolerogenic human dendritic cells.

Authors:  Mario Hubo; Bettina Trinschek; Fanny Kryczanowsky; Andrea Tuettenberg; Kerstin Steinbrink; Helmut Jonuleit
Journal:  Front Immunol       Date:  2013-04-03       Impact factor: 7.561

View more
  34 in total

Review 1.  Immunoregulation by members of the TGFβ superfamily.

Authors:  WanJun Chen; Peter Ten Dijke
Journal:  Nat Rev Immunol       Date:  2016-11-25       Impact factor: 53.106

Review 2.  The p38/MKP-1 signaling axis in oral cancer: Impact of tumor-associated macrophages.

Authors:  Zhenning Li; Fa-Yu Liu; Keith L Kirkwood
Journal:  Oral Oncol       Date:  2020-02-10       Impact factor: 5.337

3.  T Cell Receptor-Regulated TGF-β Type I Receptor Expression Determines T Cell Quiescence and Activation.

Authors:  Eric Tu; Cheryl P Z Chia; Weiwei Chen; Dunfang Zhang; Sang A Park; Wenwen Jin; Dandan Wang; Maria-Luisa Alegre; Ying E Zhang; Lingyun Sun; WanJun Chen
Journal:  Immunity       Date:  2018-04-17       Impact factor: 31.745

Review 4.  Antitumour immunity regulated by aberrant ERBB family signalling.

Authors:  Shogo Kumagai; Shohei Koyama; Hiroyoshi Nishikawa
Journal:  Nat Rev Cancer       Date:  2021-01-18       Impact factor: 60.716

5.  Differential expression of Helios, Neuropilin-1 and FoxP3 in head and neck squamous cell carcinoma (HNSCC) patients.

Authors:  A A Mohamed Adil; Anil Kumar Bommanabonia; Anandraj Vaithy; Sateesh Kumar; Mohammad Waseem; Shazia Jamal; Neesar Ahmed
Journal:  3 Biotech       Date:  2019-04-16       Impact factor: 2.406

6.  Transgene-derived overexpression of miR-17-92 in CD8+ T-cells confers enhanced cytotoxic activity.

Authors:  Akemi Kosaka; Takayuki Ohkuri; Maki Ikeura; Gary Kohanbash; Hideho Okada
Journal:  Biochem Biophys Res Commun       Date:  2015-02-10       Impact factor: 3.575

Review 7.  Tumor suppressor maspin as a modulator of host immune response to cancer.

Authors:  Sijana H Dzinic; Maria M Bernardo; Daniel S M Oliveira; Marian Wahba; Wael Sakr; Shijie Sheng
Journal:  Bosn J Basic Med Sci       Date:  2015-10-25       Impact factor: 3.363

Review 8.  Transforming growth factor-β signaling in head and neck squamous cell carcinoma: Insights into cellular responses.

Authors:  Xin Pang; Ya-Ling Tang; Xin-Hua Liang
Journal:  Oncol Lett       Date:  2018-08-17       Impact factor: 2.967

Review 9.  Aberrant miRNAs Regulate the Biological Hallmarks of Glioblastoma.

Authors:  Wanli Yu; Sai Liang; Chunzhi Zhang
Journal:  Neuromolecular Med       Date:  2018-09-04       Impact factor: 3.843

10.  Cytokines secreted by stromal cells in TNBC microenvironment as potential targets for cancer therapy.

Authors:  Marie K Malone; Karly Smrekar; Sunju Park; Brianna Blakely; Alec Walter; Nicholas Nasta; Jay Park; Michael Considine; Ludmila V Danilova; Niranjan B Pandey; Elana J Fertig; Aleksander S Popel; Kideok Jin
Journal:  Cancer Biol Ther       Date:  2020-03-26       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.